The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

10151–10175 of 17785

  • ModerateFDA (Drugs)·D-0095-2018·2017-12-06

    Faiza Beauty Cream Recalled for Marketing Without FDA Approval

    New Reliance Trading, Inc. is recalling No.1 Faiza Beauty Cream because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

    Product
    No.1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by NEW RELIANCE TRADING, INC., 5563 59th St., Maspeth, New York, 11378-2358, UPC 8993138993349, 5842109854239.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0100-2018·2017-12-06

    Vertra Sunscreen Recalled for Manufacturing Quality Deviations

    EAI-JR286 Inc. is recalling 5,355 tubes of Vertra Elemental Resistance Sunscreen due to manufacturing deviations that may impact product quality.

    Product
    Vertra Elemental Resistance (Octyl Methoxycinnamate 6%, Oxybenzone 5%, Titanium Dioxide 6.3%, Zinc Oxide 9.9%) Sun Protection Cream, SPF 50+, Net. Wt. 2.8 oz (80 g) tube in a carton, Distributed by Vertra/EAI-JR286, 20100 S Vermont Ave, Torrance, CA 90502, Made In Australia, UPC
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0098-2018·2017-12-06

    Mayne Pharma Recalls Liothyronine Sodium Tablets for Dissolution Failures

    Mayne Pharma Inc is recalling 11,364 bottles of Liothyronine Sodium Tablets 25 mcg because they failed dissolution specifications. The affected lot is distributed nationwide.

    Product
    Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0088-2018·2017-11-29

    FDA Recalls Naturally HL Hemorrhoid Spray for Manufacturing Control Issues

    Ridge Properties, LLC is recalling Naturally HL Hemorrhoid Numbing Spray due to inadequate manufacturing control processes. The product was distributed throughout the United States.

    Product
    Extra Strength Naturally HL Hemorrhoid Numbing Spray with Lidocaine, (lidocaine HCL 4%), 1/2 oz Spray (NDC 69804-015-08), 1 oz Spray (NDC 69804-015-07), 2 oz Spray (NDC 69804-015-01) and 4 oz Spray (NDC 69804-015-04) bottles, Manufactured by Pain Relief Naturally, www.Naturally H
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0089-2018·2017-11-29

    Ridge Properties Recalls Naturally HL Hemorrhoid Gel Due to Manufacturing Issues

    Ridge Properties, LLC is recalling Naturally HL Liquid Hemorrhoid Relief Gel due to inadequate manufacturing control processes. The product was distributed throughout the United States.

    Product
    Extra Strength Naturally HL Liquid Hemorrhoid Relief Gel, (lidocaine HCL 4%), 1/2 oz Liquid Gel (NDC 69804-024-13), 1 oz Liquid Gel (NDC 69804-024-14), 2 oz Liquid Gel (NDC 69804-024-15), 4 oz Liquid Gel (NDC 69804-024-16) bottles, Manufactured by Pain Relief Naturally, www.Natu
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0090-2018·2017-11-29

    FDA Recalls Naturally HL Hemorrhoid Balm for Manufacturing Control Issues

    Ridge Properties, LLC is recalling Naturally HL Hemorrhoid Numbing Balm due to inadequate manufacturing control processes. The product was distributed throughout the United States.

    Product
    Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine, (lidocaine HCL 4%), 1/2 oz Balm (NDC 69804-014-06), and 2 oz Balm(NDC 69804-014-03), Manufactured by Pain Relief Naturally, www.Naturally HL.com
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0087-2018·2017-11-29

    FDA Recalls Extra Strength PreTAT Gel Due to Manufacturing Control Issues

    Ridge Properties, LLC is recalling Extra Strength PreTAT by TAT BALM Gel because of inadequate manufacturing control processes. The product was distributed throughout the United States.

    Product
    Extra Strength PreTAT by TAT BALM Gel, (lidocaine HCL 4%), 1/2 oz Gel (NDC 69804-018-09), 1 oz Gel (NDC 69804-018-10) , 2 oz Gel (NDC 69804-018-11), and 4 oz Gel (NDC 69804-018-12) jars, Manufactured by Pain Relief Naturally, www.Naturally HL.com
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0085-2018·2017-11-29

    Lorazepam Tablets Recalled Due to Incorrect Strength Labeling

    Leading Pharma, LLC is recalling Lorazepam tablets labeled as 0.5 mg but containing 1 mg. The recall addresses a labeling error affecting 2,952 bottles nationwide.

    Product
    LORAZEPAM — LORAZEPAM (LORAZEPAM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0086-2018·2017-11-29

    Ridge Properties Recalls Bed Sore Cream Due to Manufacturing Control Issues

    Ridge Properties, LLC is recalling Extra Strength Naturally HL Bed Sore Relief Cream with Added Lidocaine due to inadequate manufacturing control processes.

    Product
    Extra Strength Naturally HL Bed Sore Relief Cream with Added Lidocaine, (lidocaine HCL 4%), 1/2 oz Balm(NDC 69804-008-06), 1 oz Balm (NDC 69804-008-05), 2 oz Balm(NDC 69804-008-02), and 4 oz Balm(NDC 69804-008-03), Manufactured by Pain Relief Naturally, www.Naturally HL.com
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0084-2018·2017-11-29

    FDA Recalls Unapproved Faiza Beauty Cream Distributed in New York

    The FDA is recalling No. 1 Faiza Beauty Cream because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

    Product
    No. 1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by Shata Traders Inc., 4, 19th Street, Brooklyn, NY 11232. UPC 5842109854239
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0083-2018·2017-11-29

    United Therapeutics Recalls Tyvaso Inhalation Devices Due to Manufacturing Deviations

    United Therapeutics is voluntarily recalling 12 Tyvaso Inhalation System Starter Kits due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0093-2018·2017-11-29

    West-Ward Recalls Dexamethasone Sodium Phosphate Injection Due to Impurities

    West-Ward Pharmaceuticals is recalling specific lots of Dexamethasone Sodium Phosphate Injection because of high out-of-specification results for a related compound.

    Product
    DEXAMETHASONE SODIUM PHOSPHATE — DEXAMETHASONE SODIUM PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0094-2018·2017-11-29

    West-Ward Recalls Dexamethasone Sodium Phosphate Injection Due to Impurity

    West-Ward Pharmaceuticals is recalling Dexamethasone Sodium Phosphate Injection due to high levels of a related compound impurity.

    Product
    DEXAMETHASONE SODIUM PHOSPHATE — DEXAMETHASONE SODIUM PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0081-2018·2017-11-22

    Llorens Pharmaceutical Recalls Urin D/S Tablets Due to Potency Issues

    Llorens Pharmaceutical Corp. is recalling Urin D/S Tablets because FDA analysis found the product to be out of specification for assay, resulting in subpotent or superpotent tablets.

    Product
    Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0076-2018·2017-11-22

    Amneal Recalls Fosphenytoin Sodium Injection Due to Particulate Matter

    Amneal Pharmaceuticals is recalling 14,000 vials of Fosphenytoin Sodium Injection because of the presence of particulate matter.

    Product
    Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL. 10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7
    Category
    Drug
    Distribution
    5 states
  • SevereFDA (Drugs)·D-0080-2018·2017-11-22

    PharMEDium Recalls Hydromorphone Injection Due to Potency Failure

    PharMEDium Services is recalling 499 syringes of Hydromorphone HCl injection because the product failed potency specifications.

    Product
    Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40
    Category
    Drug
    Distribution
    2 states
  • ModerateFDA (Drugs)·D-0079-2018·2017-11-22

    Fagron Recalls Estriol Compounding Powder Due to Quality Assurance Deviations

    Fagron, Inc. is recalling Estriol for prescription compounding due to lack of quality assurance at the API manufacturer.

    Product
    Estriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-1392-1), b) 5 G bottle (NDC: 51552-1392-2), c) 25 G bottle (NDC: 51552-1392-3) and d) 100 G bottle (NDC 51552-1392-5), Rx only, Distributed by Fagron, Inc., 2400 Pilot Knob Rd, St. Paul, MN 55120 Tel. 1
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0077-2018·2017-11-22

    Allergan Recalls Combigan Eye Drops Due to Failed Impurity Specifications

    Allergan is recalling 715,041 bottles of Combigan ophthalmic solution because the product failed impurities and degradation specifications.

    Product
    COMBIGAN — COMBIGAN (BRIMONIDINE TARTRATE, TIMOLOL MALEATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0074-2018·2017-11-22

    Amerisource Recalls Enalapril Maleate Tablets Due to Stability Failures

    Amerisource Health Services is recalling Enalapril Maleate Tablets, 5 mg, because the product failed stability specifications.

    Product
    Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-390-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0075-2018·2017-11-22

    Genzyme Recalls Clolar Injection Due to Missing Package Insert

    Genzyme Corporation is recalling Clolar (clofarabine) injection vials because the package insert is incorrect or missing.

    Product
    Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
    Category
    Drug
    Distribution
    Distributed nationwide